Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SALT LAKE CITY, UT and BOYNTON BEACH, FL--(Marketwire - Oct 22, 2011) - ADP® AdvancedMD, a leader in cloud practice management, medical scheduling software, and billing applications for...
-
BONITA SPRINGS, FL--(Marketwire - Oct 18, 2011) - EyeMD EMR Healthcare Systems, Inc. (EyeMD EMR), a leading provider of Electronic Medical Records software designed specifically for the...
-
NeutroPhase is a FDA 510(k) cleared advanced wound care product addressing the un-met medical needs of the six-million-patient USA chronic wound care market EMERYVILLE, Calif., Oct. 14, 2011...
-
SAN DIEGO, CA--(Marketwire - Oct 12, 2011) - San Diego LASIK surgeon Dr. Max Parikh, M.D. of NVISION Laser Eye Centers in La Jolla was named Top Doc by San Diego Magazine. Dr. Parikh was one of...
-
ATLANTA, Oct. 12, 2011 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc., (Nasdaq:ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of...
-
Former Alcon Executive With Significant Experience in Ophthalmic Drug Development to Oversee NovaBay's Program for Viral Conjunctivitis (Pink Eye) EMERYVILLE, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE)...
-
Executive With Three Decades of Experience in Medical Products Industry to Oversee NovaBay's Commercial Launch of NeutroPhase® EMERYVILLE, Calif., Sept. 28, 2011 (GLOBE NEWSWIRE) --...
-
SINGAPORE--(Marketwire - Sep 27, 2011) - Hyphens Pharma, a specialty pharmaceutical company focusing on innovative gastroenterology products, is organizing two talks on October 8th, 2011 at the...
-
Management to Present at 1:00 PM PDT / 4:00 PM EDT on September 22, 2011 EMERYVILLE, Calif., Sept. 21, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage...
-
Alcon is innovative new growth platform with leading position in eye care segment Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability ...